The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Shin Nippon Biomedical Laboratories, Ltd. since 2015.
This trader's CIK number is 1657770.
At the time of last reporting, Shin Nippon Biomedical Laboratories, Ltd. was the 10% Owner of Satsuma Pharmaceuticals, Inc.. (stock ticker symbol STSA).
Also see all insider trading activities at Satsuma Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | WVE | 125,000 | $2,000,000 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | STSA | 30,477,313 | $27,734,354 | 0 | $0 | 0 | $0 |
1. Wave Life Sciences Ltd. (WVE)
2. Satsuma Pharmaceuticals, Inc. (STSA)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-11-16 | WVE | Buy | 125,000 | 16.00 | 2,000,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-06-06 | STSA | Buy | 22,053,581 | .91 | 20,068,758 |
2023-06-08 | STSA | Buy | 8,423,732 | .91 | 7,665,596 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shin Nippon Biomedical Laboratories, Ltd. (10% Owner of Satsuma Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.